Objective: Guidelines define hypertension diagnosed before 20 weeks' gestation as chronic hypertension (CH) and thereafter as gestational hypertension (GH). We tested whether hypertension diagnosed before 20 weeks is preceded by CH and whether pregnancy outcome depends on the time of onset of hypertension.

Design: Retrospective cohort study.

Setting: Tertiary obstetric center.

Population: Women with a history of obstetric vascular complications.

Methods: Blood pressure data prior to and during pregnancy and subsequent maternal and neonatal outcome were reviewed in 148 women. Women were grouped according to the onset of hypertension; pre-pregnancy (CH), before 20 weeks' (early GH), after 20 weeks' gestation (late GH) and normotensive.

Main Outcome Measures: Onset of hypertension, obstetric complications (pre-eclampsia, HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome, intra-uterine growth restriction).

Results: Twenty-nine women had CH. Early GH occurred in 46 women and another 32 developed late GH. Of 75 women with hypertension in the first half of pregnancy, 29 (39%) had CH and 46 (61%) early GH. Obstetric complications occurred more often in all hypertensive women, but no differences between the CH and GH groups could be detected.

Conclusions: Hypertension detected in the first half of pregnancy does not necessarily indicate chronic hypertension. Hypertension in general is related to hypertensive maternal complications and fetal growth restriction. Differentiating between chronic or gestational hypertension does not seem to help in establishing the risk for later hypertensive sequelae or intra-uterine growth restriction.

Download full-text PDF

Source
http://dx.doi.org/10.1111/aogs.12061DOI Listing

Publication Analysis

Top Keywords

hypertension
12
chronic hypertension
12
hypertension diagnosed
8
20 weeks' gestation
8
gestational hypertension
8
onset hypertension
8
obstetric complications
8
intra-uterine growth
8
half pregnancy
8
growth restriction
8

Similar Publications

Role of Glucagon-Like Peptide-1 Receptor Agonists in People With Infertility and Pregnancy.

Obstet Gynecol

January 2025

Department of Obstetrics and Gynecology and the Division of Maternal Fetal Medicine, University of Kansas School of Medicine, Kansas City, Kansas.

Obesity is a chronic condition that causes significant morbidity and mortality in people in the United States and around the world. Traditional means of weight loss include diet, exercise, behavioral modifications, and surgery. New weight loss medications, glucagon-like peptide-1 receptor agonists, are revolutionizing the management of weight loss but have implications for fertility and pregnancy.

View Article and Find Full Text PDF

Randomized clinical trials and clinical practice guidelines recommend the use of self-measured blood pressure (SMBP) to help improve the treatment of patients with hypertension. Many clinicians use SMBP in their practices, but there is significant variability in how SMBP is implemented in their day-to-day practice. This quality improvement study details the pragmatic and real-world approach clinicians and administrators used at 3 sites of the IHA Medical Group, a part of Trinity Healthcare, to implement the American Medical Association (AMA) 7-Step SMBP framework as part of the larger AMA hypertension quality improvement program AMA MAP BP.

View Article and Find Full Text PDF

Decoding lysosome communication.

Science

January 2025

Institute for Lung Health (ILH), Justus Liebig University, Giessen, Germany.

Lysosome interaction with other organelles may be linked to pulmonary hypertension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!